cigna glp-1 coverage news drops of obesity drugs for its own employees CMS Extends Medicare's Short-Term Bridge

The FDA removed semaglutide from the drug shortage list in February 2025 and tirzepatide in December 2024

[4] Always check your specific product's prescribing information for complete storage requirements

doi: 10.1126/scitranslmed.abf8396 13 FukudaKStrausSEHickieISharpeMCDobbinsJGKomaroffA

The product is manufactured at FDA-registered facilities under Current Good Manufacturing Practice (cGMP) regulations

Gluten, Corn, Yeast, Artificial Colors, Artificial Flavors

Year over year, the growth of Medicare Advantage brings more choices and coverage so we can meet diverse health needs across Texas. The expansion is not just geographic